Bilayer Tablet Formulation of Metformin HCl and Acarbose: A Novel Approach To Control Diabetes

References

1. 1.↵
   1. Bhagyalakshmi J.,
   2. Krishna P.,
   3. Ravi T. K.

   Bilayer tablet formulation of metformin hydrochloride and glipizide: a novel approach in the treatment of diabetes. Int. J. Pharm. Sci. Rev. Res. 2011, 8 (2), 209–214.

   OpenUrl
2. 2.↵
   1. Costa P.,
   2. Lobo J. M.

   Modeling and comparison of dissolution profiles. Eur. J. Pharm. Sci. 2001, 13 (2), 123–133.

   OpenUrlCrossRefPubMedWeb of Science
3. 3.↵
   1. Fassihi R. A.,
   2. Ritschel W. A.

   Multiple-layer, direct-compression, controlled-release system: in vitro and in vivo evaluation. J. Pharm. Sci. 1993, 82 (7), 750–475.

   OpenUrlPubMed
4. 4.↵
   Indian Pharmacopoeia. The Controller of Publications: New Delhi, 1996; Vol. 2, p 736.

   OpenUrl
5. 5.↵
   1. Huang J.,
   2. Li Y.,
   3. Wigent R. J.,
   4. Malick W. A.,
   5. Sandhu H. K.,
   6. Singhal D.,
   7. Shah N. H.

   Interplay of formulation and process methodology on the extent of nifedipine molecular dispersion in polymers. Int. J. of Pharm. 2011, 420 (1), 59–67.

   OpenUrl
6. 6.↵
   1. Kumar A.,
   2. Agarwal S. P.,
   3. Khanna R.

   Modified release bi-layered tablet of melatonin using beta-cyclodextrin. Pharmazie 2003, 58 (9), 642–644.

   OpenUrlPubMed
7. 7.↵
   1. Kumar V. B.,
   2. Prasad G.,
   3. Ganesh B.,
   4. Swathi C.,
   5. Rashmi A.,
   6. Reddy A. G.

   Development and evaluation of guaifenesin bilayer tablet. Int. J. Pharm. Sci. Nanotechnol. 2010, 3 (3), 1122–1127.

   OpenUrl
8. 8.↵
   1. Lachman L.,
   2. Liberman H. A.,
   3. Kanig L. J.

   The Theory and Practice of Industrial Pharmacy; Lea & Febiger: Philadelphia, PA, 1986; pp 67–69, 296–302, 316–318.
9. 9.↵
   1. Lopes C. M.,
   2. Sousa J. M.,
   3. Pinto J. F.,
   4. Costa P. C.

   Compressed matrix core tablet as a quick/slow dual-component delivery system containing ibuprofen. AAPSPharm SciTech 2007, 8 (3), E195–E202.

   OpenUrl
10. 10.
    1. Maggi L.,
    2. Machiste E. O.,
    3. Torre M. L.,
    4. Conte U.

    Formulation of biphasic release tablets containing slightly soluble drugs. Eur. J. Pharm. Biopharm. 1999, 48 (1), 37–42.

    OpenUrlPubMed
11. 11.↵
    1. Pathak D.,
    2. Dahiya S.,
    3. Pathak K.

    Solid dispersion of meloxicam: factorially designed dosage form for geriatric population. Acta Pharm. 2008, 58 (1), 99–110.

    OpenUrlPubMed
12. 12.
    1. Patra C. N.,
    2. Kumar A. B.,
    3. Pandit H. K.,
    4. Singh S. P.,
    5. Devi M. V.

    Design and evaluation of sustained release bilayer tablets of propranolol hydrochloride. Acta Pharm. 2007, 57 (4), 479–89.

    OpenUrlPubMed
13. 13.↵
    1. Perioli L.,
    2. Ambrogi V.,
    3. Giovagnoli S.,
    4. Ricci M.,
    5. Blasi P.,
    6. Rossi C.

    Mucoadhesive bilayered tablets for buccal sustained release of flurbiprofen. AAPS PharmSciTech 2007, 8 (3), E20–E27.

    OpenUrl
14. 14.↵
    1. Ramesh D. S.,
    2. Guruvaiah H.

    A Formulation and evaluation of bilayered sustained release matrix tablets of metformin HCl Sr and pioglitazone. American-Eurasian J. Sci. Res. 2010, 5 (3), 176–182.

    OpenUrl
15. 15.↵
    1. Aulton M. E.

    1. Staniforth J.

    Powder Flow. In Pharmaceutics—The Science of Dosage Form Design, Aulton M. E., Ed.; Churchill Livingstone: London, 2002; pp 198–210.
16. 16.
    1. Uekama K.,
    2. Matsubara K.,
    3. Abe K.,
    4. Horiuchi Y.,
    5. Hirayamma F.,
    6. Suzuki N.

    Design and in vitro evaluation of slow-release dosage form of piretanide: utility of beta cyclodextrin: cellulose derivative combination as a modified-release drug carrier. J. Pharm. Sci. 1990, 79 (3), 244–248.

    OpenUrlPubMed
17. 17.↵
    United States Pharmacopoeia XXIV. National Formulary 19. United States Pharmacopoeial Convention: Rockville, MD, 2000; pp 1913–1914, 2235–2236.
18. 18.
    1. Wang Z.,
    2. Horikawa T.,
    3. Hirayama F.,
    4. Uekama K.

    Design and in-vitro evaluation of a modified-release oral dosage form of nifedipine by hybridization of hydroxypropyl-beta-cyclodextrin and hydroxypropylcellulose. J. Pharm. Pharmacol. 1993, 45 (11), 942–946.

    OpenUrlPubMed
19. 19.↵
    1. Yang M.

    Solid dispersion of acetaminophen and poly(ethylene oxide) prepared by hot-melt mixing. Int. J. Pharm. 2010, 395 (1), 53–61.

    OpenUrlPubMed
20. 20.
    1. Hamza Y. E. S.,
    2. Aburahma M. H.

    Design and in vitro evaluation of novel sustained-release double-layer tablets of lornoxicam: utility of cyclodextrin and xanthan gum combination. AAPS PharmSciTech 2009, 10 (4), 1357–1367.

    OpenUrlPubMed